Newsroom
The Next HIX Challenge: Formulary, Network Comparison Tools
Left as-is, current exchange formuarly and network search technology has the potential for a lot of consumer dissatisfaction and backlash.
Illinois Medicaid Moves To Managed Care
Hundreds of thousands of Medicaid recipients in Illinois are being shifted into some kind of managed care this year as part of a sweeping overhaul intended to fix a program widely acknowledged to be broken.
Mesothelioma Diagnostic Test that Predicts Survival Now Available
Validation studies presented at the annual meeting of the American Association for Thoracic Surgery push availability of the DecisionDx-Mesothelioma molecular test through an early access program.
Company Halts Sale of Laproscopic Power Morcellators Used in Fibroid Surgery
Following a FDA advisory earlier in the month of an increased risk of cancer spread, Johnson and Johnson suspended the global sale of a device used in fibroid surgery.
Early Diagnosis Key to Getting Rheumatoid Arthritis Patients to 'Target, Leading Academic Physicians Agree
Two leading academic rheumatologists who took part in a live discussion with A. Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care, agreed that getting an accurate early diagnosis of rheumatoid arthritis (RA) is key to getting the patient started on disease modifying therapy. Today's goal, they said, is remission of the disease, not just managing symptoms.
Zykadia Approved for Late-Stage ALK+ NSCLC
The US FDA today approved Zykadia (ceritinib), a ALK tyrosine kinase inhibitor developed by Novartis, for treatment of late-stage NSCLC.
Affordable Drug Choices More Limited in Medicare, Study Finds
The American Journal of Managed Care publishes a first-of-its-kind study comparing different types of health insurance plans and different levels of co-payment, to see how varieties of coverage affect access to therapeutic drug classes.
Drug Monitoring Information Improves Regimen Adherence, Researchers Say
Most people want to take medications as prescribed, even if they sometimes need a little help remembering. For them, an automated system that monitors drug taking and provides feedback after the fact may be more useful than one that nags people when it is time to take a pill, researchers at Carnegie Mellon University say.
Coordinated Care Alone May Not Yield ROI, ACPE Told
A federally funded effort to identify high-risk patients and coordinate their care is delivering modest savings, but significant cost reductions may come only after broader payment reforms take hold.
Evidence-Based Collaborative Program for Cancer Care Launched in California
A collaboration between Aetna, MOASC Contracting Network and Cardinal Health Specialty Solutions aims to improve quality and cost of cancer care in California.
Sativex Receives Fast Track Status for Advanced Cancer Pain
Sativex,a cannabinoid developed together by GW Pharmaceuticals and Otsuka, receives FDA's Fast Track status for advanced cancer pain.
3D Printing Could Improve Drug Discovery and Development
3D printing of tumors could provide a more physiological environment to boost cancer drug discovery and development.
Healthcare Costs Among Young Adults Are About The Same, Whether They're Insured Or Not
Among surprises from a new study on U.S. health spending is the realization: Whether insured or not, young adults spent about the same on out-of-pocket health expenditures throughout the year.
Bonuses Still Tied to Better Financials
Quality-of-care performance means more to CEO paychecks at some for-profit hospital companies than at others.
Study: Costly Breast Cancer Treatment More Common At For-Profit Hospitals
Older breast cancer patients who received radiation treatment after surgery were more likely to undergo a more expensive and somewhat controversial type of radiation called brachytherapy if they got their care at for-profit rather than nonprofit hospitals, a new study reports.
PD-L1: Immunotherapy Response Biomarker in Lung Cancer?
PD-L1 protein levels could be an important biomarker to predict response to immunotherapy in NSCLC patients.
Phase III SYNERGY Trial: Disappointing Results in Metastatic CRPC
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. today announced results from the Phase III SYNERGY trial, a randomized, open-label, two-arm study comparing the combination of custirsen and standard first-line docetaxel/prednisone therapy to docetaxel/prednisone alone in men with metastatic castrate-resistant prostate cancer (CRPC)
ICD-10 Delay Derails More Than IT for Health Insurers
With the delay in ICD-10, many insurers now have to slow down a mammoth IT project and, potentially more disruptive, make adjustments to a whole slew of programs and contracts.
Could Managed Care Offset OK's Surge in Medicaid Spending for Emergency Room Visits?
Medicaid-financed emergency room costs statewide grew nearly $10 million to $178.3 million in fiscal year 2013.
ASTRO's New Guidelines on Post-operative Radiation Therapy for Endometrial Cancer
The American Society for Radiation Oncology (ASTRO) has issued a new guideline, The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline, that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline's executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an open-access article online.
Promising AML Treatment to Initiate Phase III Trial at Moffitt
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation.
First Human HPV DNA Test for Cervical Cancer Screening Receives FDA Nod
The U.S. Food and Drug Administration today approved the first FDA-approved HPV DNA test for women 25 and older that can be used alone to help a health care professional assess the need for a woman to undergo additional diagnostic testing for cervical cancer. The test also can provide information about the patient's risk for developing cervical cancer in the future.
Physician Payment Data is Where the Action Is
Look beyond the EHR incentive program. A national effort to turn CMS's recent release of Medicare physician payment data into useful, actionable data visualizations is the hottest HIT challenge right now.
The Changing World of Oncology Reimbursement, Are You Ready?
The expenses associated with cancer care in the United States are staggering and only expected to climb.